Recombinant Human Albumin Injection

recombinant human albumin · Tonghua Anrate Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant Human Albumin Injection, covering 2024-05-13 to 2025-04-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites [Phase 3]

See pricing